Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1/2 8Phase 1 8Phase 3 4Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4Prostatic Diseases 1Prostate Cancer Metastatic 1Kidney Neoplasms 1Genital Diseases, Male 1Carcinoma, Renal Cell 1

Interventions

Prednisone 53Radiotherapy 52Docetaxel 51Leuprolide 48Goserelin 47bicalutamide 45enzalutamide 28acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 27Androgen Antagonists 27Flutamide 24Triptorelin Pamoate 22apalutamide 18Gonadotropin-Releasing Hormone 18Abiraterone Acetate 17Radiation 15abiraterone 14Zoledronic Acid 14Magnetic Resonance Spectroscopy 13gallium 68 PSMA-11 12Prednisolone 11luprolide acetate gel depot 10darolutamide 9Radiosurgery 9cabazitaxel 8Standard of Care 8Specimen Handling 8Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Estramustine 8Dexamethasone 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Prostatic Neoplasms × Pluvicto × Clear all
NCT04720157 2026-05-27

PSMAddition

Novartis

Phase 3 Active not recruiting
1,140 enrolled
Genitourinary

Prostatic Neoplasms

NCT04689828 2026-03-23

PSMAfore

Novartis

Phase 3 Active not recruiting
469 enrolled 11 charts 1 FDA
Genitourinary

Prostatic Neoplasms

NCT07200830 2025-10-01

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Alliance for Clinical Trials in Oncology

Phase 3 Not yet recruiting
1,524 enrolled
Genitourinary

Prostatic Neoplasms

NCT03511664 2025-01-13

VISION

Endocyte

Phase 3 Completed
861 enrolled 39 charts 1 FDA
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡